By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Synthetic biology firm Intrexon today announced the close of its Series E round of financing, which raised $100 million and brings the total capital raised by the company in its history to more than $259 million.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.
Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.
Broken links are found throughout academic publications, and some services are trying to combat such link decay.
Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.